DIA514.27-18.84 -3.53%
SPY733.00-33.81 -4.41%
QQQ647.05-44.90 -6.49%

This Kazia Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday

Benzinga·10/30/2026 14:28:59
Listen to the news

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Needham analyst Gil Blum initiated coverage on Kazia Therapeutics Limited (NASDAQ:KZIA) with a Buy rating and announced a price target of $27. Kazia Therapeutics closed at $8.72 on Thursday. See how other analysts view this stock.
  • Cantor Fitzgerald analyst Troy Jensen initiated coverage on Pasqal Holding SA (NASDAQ:PSQL) with an Overweight rating and announced a price target of $12. Pasqal Holding shares closed at $5.24 on Thursday. See how other analysts view this stock.
  • Maxim Group analyst Naz Rahman initiated coverage on Nasus Pharma Ltd. (AMEX:NSRX) with a Buy rating and announced a price target of $7. Nasus Pharma closed at $3.19 on Thursday. See how other analysts view this stock.
  • Maxim Group analyst Anthony Vendetti initiated coverage on Legacy Education Inc. (AMEX:LGCY) with a Buy rating and announced a price target of $16. Legacy Education shares closed at $10.22 on Thursday. See how other analysts view this stock.

Considering buying KZIA stock? Here’s what analysts think:

Photo via Shutterstock

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.